GPI facility inspection classified as Voluntary Action Indicated
Granules India announced that its wholly owned foreign subsidiary, Granules Pharmaceuticals, Inc. has received a communication from the US FDA indicating the inspection classification as Voluntary Action Indicated. (VAI).
Previously, USFDA issued 6 observations under Form 483 on inspection of its facility located at Chantilly, Virginia, USA.
The VAI inspection classification indicates that the US FDA will not take or recommend regulatory or enforcement action because the observations do not meet the threshold for action at this time.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Buzzing :
Greece in crisisTravel & Budget & EuropeSaaS $ Email MarketingHarnautBlacklisting Policy 2Question Paper Leak 2A big moment for small armsAI in Financial Markets: How Technology is Changing Investing'India's size and diversity make it a powerful innovation engine'Datanomics: Housing, gold loans drive household debt to a decade highSamrat ChoudharyEl Nino
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 26 2022 | 9:13 AM IST